Company Herborium Group, Inc. Other OTC
Equities
HBRM
US42703A2087
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Botanical Therapeutics
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -1.21% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -1.21% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Agnes Olszewski
CEO | Chief Executive Officer | 67 | 04/02/04 |
John Donahue
AUD | Comptroller/Controller/Auditor | 74 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Agnes Olszewski
CEO | Chief Executive Officer | 67 | 04/02/04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,919,428,835 | 10,919,428,835 ( 100.00 %) | 0 | 100.00 % |
Stock B | 0 | 4,000,000 | 0 | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+9.58% | 115B | |
+12.41% | 107B | |
-3.11% | 21.6B | |
-12.38% | 22.31B | |
-5.29% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |